DD281385A5 - Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat - Google Patents

Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat Download PDF

Info

Publication number
DD281385A5
DD281385A5 DD88315013A DD31501388A DD281385A5 DD 281385 A5 DD281385 A5 DD 281385A5 DD 88315013 A DD88315013 A DD 88315013A DD 31501388 A DD31501388 A DD 31501388A DD 281385 A5 DD281385 A5 DD 281385A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
acid
compound
ether
mixture
Prior art date
Application number
DD88315013A
Other languages
German (de)
English (en)
Inventor
Andrew G Brewster
George R Brown
Reginald Jessup
Michael J Smithers
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD281385A5 publication Critical patent/DD281385A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD88315013A 1987-04-24 1988-04-22 Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat DD281385A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709794A GB8709794D0 (en) 1987-04-24 1987-04-24 Heterocyclic acids

Publications (1)

Publication Number Publication Date
DD281385A5 true DD281385A5 (de) 1990-08-08

Family

ID=10616328

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88315013A DD281385A5 (de) 1987-04-24 1988-04-22 Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat

Country Status (21)

Country Link
US (1) US4921866A (ja)
EP (1) EP0288279B1 (ja)
JP (1) JP2620298B2 (ja)
KR (1) KR880012583A (ja)
CN (1) CN1015893B (ja)
AU (1) AU609466B2 (ja)
CA (1) CA1312084C (ja)
DD (1) DD281385A5 (ja)
DE (1) DE3874394T2 (ja)
DK (1) DK217388A (ja)
FI (1) FI881829A (ja)
GB (2) GB8709794D0 (ja)
HU (1) HU204522B (ja)
IL (1) IL86066A (ja)
MY (1) MY103368A (ja)
NO (1) NO171211C (ja)
NZ (1) NZ224345A (ja)
PL (1) PL272024A1 (ja)
PT (1) PT87301B (ja)
ZA (1) ZA882528B (ja)
ZW (1) ZW3888A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
DE4018260A1 (de) * 1990-06-07 1991-12-12 Basf Ag Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
ES2609825T3 (es) * 2007-01-18 2017-04-24 Evolva Sa 1,3-Dioxanos sustituidos útiles como moduladores de PPAR
DE102007010077B4 (de) 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
EP4190308A1 (de) 2021-12-06 2023-06-07 Marome GmbH Schlafduft sowie herstellung und verwendung von diesem

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
GB8511896D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenes
DE3685775T2 (de) * 1985-05-10 1993-01-21 Ici Plc Alkenderivate.
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives

Also Published As

Publication number Publication date
US4921866A (en) 1990-05-01
NO881768D0 (no) 1988-04-22
AU609466B2 (en) 1991-05-02
ZA882528B (en) 1988-10-24
FI881829A (fi) 1988-10-25
IL86066A0 (en) 1988-09-30
DE3874394D1 (en) 1992-10-15
HU204522B (en) 1992-01-28
CN1015893B (zh) 1992-03-18
NO171211C (no) 1993-02-10
AU1476188A (en) 1988-10-27
JP2620298B2 (ja) 1997-06-11
DK217388A (da) 1988-10-25
JPS63280082A (ja) 1988-11-17
GB8808338D0 (en) 1988-05-11
PL272024A1 (en) 1989-01-23
FI881829A0 (fi) 1988-04-19
DE3874394T2 (de) 1993-02-25
EP0288279A3 (en) 1990-05-30
ZW3888A1 (en) 1989-11-22
DK217388D0 (da) 1988-04-21
NO171211B (no) 1992-11-02
CN88102356A (zh) 1988-12-28
HUT50157A (en) 1989-12-28
MY103368A (en) 1993-06-30
EP0288279A2 (en) 1988-10-26
NZ224345A (en) 1991-07-26
EP0288279B1 (en) 1992-09-09
IL86066A (en) 1992-11-15
CA1312084C (en) 1992-12-29
PT87301B (pt) 1992-08-31
GB8709794D0 (en) 1987-05-28
NO881768L (no) 1988-10-25
PT87301A (pt) 1988-05-01
KR880012583A (ko) 1988-11-28

Similar Documents

Publication Publication Date Title
EP0546388B1 (de) Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
DE68926144T2 (de) Pyridinderivate
DD300434A5 (de) Heterozyklische derivate
DE60128912T9 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
DE3788982T2 (de) Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
EP0934311A2 (de) Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen
DD219769A5 (de) Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten
DE69008791T2 (de) Benzopyranverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen.
DE3200304A1 (de) 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3884133T2 (de) Antihypertensive Benzopyran-Derivate.
DE69217308T2 (de) Dihydropyridine zur Anwendung in der Antitumor-Therapie
DE2940833A1 (de) 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DD281385A5 (de) Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat
US4937242A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
EP0546389B1 (de) Piperidylmethyl substituierte Chromanderivate als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
JPS60214778A (ja) Ν置換3,4−ジヒドロピリミジン誘導体ならびにその製造法および用途
EP0749970B1 (de) Benzisothiazolyl-substituierte Aminomethylchromane
DD251749A5 (de) Verfahren zur herstellung von 2,4-diphenyl-1,3-dioxian-derivaten
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
DE68917170T2 (de) Pyridin-Derivate.
EP0539803A1 (de) Triazaspirodecanon-Methyl-Chromane zur Bekämpfung von Erkrankungen des Zentralnervensystems
US4992441A (en) 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia
DE3685775T2 (de) Alkenderivate.
DE3782396T2 (de) Pharmazeutische zusammensetzungen, enthaltend ein 2,4-diphenyl-1,3-dioxane derivat und einen inhibitor des thromboxan a2 synthese.
DE2549568C3 (de) 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee